John P. Finnigan - Concepedia

Author

John P. Finnigan

Icahn School of Medicine at Mount Sinai ORCID

Also Known As

Finnigan, John P., John Finnigan, John P Finnigan, John P. Finnigan, John Patrick Finnigan

Publications

1.5K

Citations

H-Index

Concepts

All Affiliations

Icahn School of Medicine at Mount Sinai New York University National Institute of Allergy and Infectious Diseases Rockefeller University AVEO Oncology (United States)

About

John P. Finnigan is an author at Icahn School of Medicine at Mount Sinai specializing in immunology, medicine, and cell biology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	4	4	1.1K
2	Immunology	4	4	1.1K
3	Cell Biology	3	3	1.1K
4	Engineering	1	1	197
5	Dendritic Cell Biology	1	1	21

John P. Finnigan

Publications

1.4K

Citations

H-Index

Page 1

	Year	Citations
A conserved dendritic-cell regulatory program limits antitumour immunity Bárbara Maier, Andrew M. Leader, Steven T. Chen, Nature Cancer ImmunosurveillanceImmune RegulationImmunologyImmunotherapyMedicine	2020	884
Intravenous nanoparticle vaccination generates stem-like TCF1+ neoantigen-specific CD8+ T cells Faezzah Baharom, Ramiro A. Ramirez-Valdez, Kennedy K.S. Tobin, Nature Immunology VaccinationNanomedicineEngineeringImmunoengineeringImmunology	2020	197
Immune Checkpoint Blockade Enhances Shared Neoantigen-Induced T-cell Immunity Directed against Mutated Calreticulin in Myeloproliferative Neoplasms Cansu Cimen Bozkus, Vladimir Roudko, John P. Finnigan, Cancer Discovery	2019	96
Mutation-derived Neoantigen-specific T-cell Responses in Multiple Myeloma Deepak Perumal, Naoko Imai, Alessandro Laganà, Clinical Cancer Research	2019	84
Computational Pipeline for the PGV-001 Neoantigen Vaccine Trial Alex Rubinsteyn, Julia Kodysh, Isaac Hodes, Frontiers in Immunology	2018	72
<i>TGF</i> β Receptor 1: An Immune Susceptibility Gene in HPV-Associated Cancer Chaya Levovitz, Dan Chen, Emma Ivansson, Cancer Research	2014	50
Author Correction: A conserved dendritic-cell regulatory program limits antitumour immunity Bárbara Maier, Andrew M. Leader, Steven T. Chen, Nature Cancer ImmunosurveillanceImmunologyTumor ImmunityImmune RegulationT Cell Immunity	2020	21
Mutation-Derived Tumor Antigens: Novel Targets in Cancer Immunotherapy. John P. Finnigan, Alex Rubinsteyn, Jeff Hammerbacher, PubMed Tumor ImmunologyCancer ImmunosurveillanceExciting New ClassMedicineMutation-derived Tumor Antigens	2015	14
Structural basis for self-discrimination by neoantigen-specific TCRs John P. Finnigan, Jenna H. Newman, Y. Patskovsky, Nature Communications	2024	13
PGV001, a Multi-Peptide Personalized Neoantigen Vaccine Platform: Phase I Study in Patients with Solid and Hematologic Malignancies in the Adjuvant Setting Mansi Saxena, Thomas U. Marron, Julia Kodysh, Cancer Discovery	2025	12

Page 1